Pang-Kuo Lo

Pang-Kuo Lo is an accomplished scientist with extensive experience in pre-clinical research, specializing in oncological and immuno-oncological studies. Currently serving as Team Lead of Assay Development and Study Director at Noble Life Sciences Inc since July 2020, Pang-Kuo designs and implements various studies alongside conducting bioinformatics analyses. Prior to this role, significant contributions were made at the University of Maryland School of Medicine, where Pang-Kuo engaged in next-generation sequencing projects, utilizing machine learning for data analysis, leading to published work. Previous positions include Research Associate at Florida State University, where Pang-Kuo performed bioinformatics analysis and published findings, and Research Scientist at the University of South Carolina, contributing to breast cancer research. A Doctor of Philosophy in Biochemistry and Molecular Biology was obtained from National Yang Ming University, complemented by master's degrees and a pharmacy degree.